Patent · US Active

GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis

US11801293B2 · kind B2 · utility

0Cited by
16References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 30, 2020
Grant dateOct 31, 2023
Priority date
Expiry dateJun 13, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/825
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention generally provides methods and compositions for eliciting an immune response against Neisseria spp. bacteria in a subject, particularly against a Neisseria meningitidis serogroup B strain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.